173 related articles for article (PubMed ID: 30150402)
1. Pyruvate dehydrogenase phosphatase catalytic subunit 2 limits Th17 differentiation.
Kono M; Yoshida N; Maeda K; Skinner NE; Pan W; Kyttaris VC; Tsokos MG; Tsokos GC
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):9288-9293. PubMed ID: 30150402
[TBL] [Abstract][Full Text] [Related]
2. Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus-like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis.
Kono M; Yoshida N; Maeda K; Suárez-Fueyo A; Kyttaris VC; Tsokos GC
Arthritis Rheumatol; 2019 Nov; 71(11):1869-1878. PubMed ID: 31233276
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional factor ICER promotes glutaminolysis and the generation of Th17 cells.
Kono M; Yoshida N; Maeda K; Tsokos GC
Proc Natl Acad Sci U S A; 2018 Mar; 115(10):2478-2483. PubMed ID: 29463741
[TBL] [Abstract][Full Text] [Related]
4. ICER is requisite for Th17 differentiation.
Yoshida N; Comte D; Mizui M; Otomo K; Rosetti F; Mayadas TN; Crispín JC; Bradley SJ; Koga T; Kono M; Karampetsou MP; Kyttaris VC; Tenbrock K; Tsokos GC
Nat Commun; 2016 Sep; 7():12993. PubMed ID: 27680869
[TBL] [Abstract][Full Text] [Related]
5. CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance.
Koga T; Hedrich CM; Mizui M; Yoshida N; Otomo K; Lieberman LA; Rauen T; Crispín JC; Tsokos GC
J Clin Invest; 2014 May; 124(5):2234-45. PubMed ID: 24667640
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells facilitate the nuclear accumulation of inducible cAMP early repressor (ICER) and suppress nuclear factor of activated T cell c1 (NFATc1).
Vaeth M; Gogishvili T; Bopp T; Klein M; Berberich-Siebelt F; Gattenloehner S; Avots A; Sparwasser T; Grebe N; Schmitt E; Hünig T; Serfling E; Bodor J
Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2480-5. PubMed ID: 21262800
[TBL] [Abstract][Full Text] [Related]
7. Elevated expression of microRNA-873 facilitates Th17 differentiation by targeting forkhead box O1 (Foxo1) in the pathogenesis of systemic lupus erythematosus.
Liu L; Liu Y; Yuan M; Xu L; Sun H
Biochem Biophys Res Commun; 2017 Oct; 492(3):453-460. PubMed ID: 28837808
[TBL] [Abstract][Full Text] [Related]
8. cAMP-responsive element modulator α (CREMα) suppresses IL-17F protein expression in T lymphocytes from patients with systemic lupus erythematosus (SLE).
Hedrich CM; Rauen T; Kis-Toth K; Kyttaris VC; Tsokos GC
J Biol Chem; 2012 Feb; 287(7):4715-25. PubMed ID: 22184122
[TBL] [Abstract][Full Text] [Related]
9. Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus.
Koga T; Sato T; Furukawa K; Morimoto S; Endo Y; Umeda M; Sumiyoshi R; Fukui S; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Origuchi T; Nakamura H; Kawakami A
Arthritis Rheumatol; 2019 May; 71(5):766-772. PubMed ID: 30462889
[TBL] [Abstract][Full Text] [Related]
10. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.
Gerriets VA; Kishton RJ; Nichols AG; Macintyre AN; Inoue M; Ilkayeva O; Winter PS; Liu X; Priyadharshini B; Slawinska ME; Haeberli L; Huck C; Turka LA; Wood KC; Hale LP; Smith PA; Schneider MA; MacIver NJ; Locasale JW; Newgard CB; Shinohara ML; Rathmell JC
J Clin Invest; 2015 Jan; 125(1):194-207. PubMed ID: 25437876
[TBL] [Abstract][Full Text] [Related]
11. IL-6/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation.
Zhao M; Tan Y; Peng Q; Huang C; Guo Y; Liang G; Zhu B; Huang Y; Liu A; Wang Z; Li M; Gao X; Wu R; Wu H; Long H; Lu Q
Nat Commun; 2018 Feb; 9(1):583. PubMed ID: 29422534
[TBL] [Abstract][Full Text] [Related]
12. Phosphatase PP2A is essential for T
Xu Q; Jin X; Zheng M; Rohila D; Fu G; Wen Z; Lou J; Wu S; Sloan R; Wang L; Hu H; Gao X; Lu L
Proc Natl Acad Sci U S A; 2019 Jan; 116(3):982-987. PubMed ID: 30593560
[TBL] [Abstract][Full Text] [Related]
13. The deacetylase SIRT2 contributes to autoimmune disease pathogenesis by modulating IL-17A and IL-2 transcription.
Hisada R; Yoshida N; Umeda M; Burbano C; Bhargava R; Scherlinger M; Kono M; Kyttaris VC; Krishfield S; Tsokos GC
Cell Mol Immunol; 2022 Jun; 19(6):738-750. PubMed ID: 35523941
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T-cells and cAMP suppress effector T-cells independently of PKA-CREM/ICER: a potential role for Epac.
Vang AG; Housley W; Dong H; Basole C; Ben-Sasson SZ; Kream BE; Epstein PM; Clark RB; Brocke S
Biochem J; 2013 Dec; 456(3):463-73. PubMed ID: 24007532
[TBL] [Abstract][Full Text] [Related]
15. [Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus].
Guo Q; Chen XY; Su Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1100-1104. PubMed ID: 27987522
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional activation of the cAMP-responsive modulator promoter in human T cells is regulated by protein phosphatase 2A-mediated dephosphorylation of SP-1 and reflects disease activity in patients with systemic lupus erythematosus.
Juang YT; Rauen T; Wang Y; Ichinose K; Benedyk K; Tenbrock K; Tsokos GC
J Biol Chem; 2011 Jan; 286(3):1795-801. PubMed ID: 21097497
[TBL] [Abstract][Full Text] [Related]
17. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
[TBL] [Abstract][Full Text] [Related]
18. Role of CREM in systemic lupus erythematosus.
Xu WD; Zhang YJ; Wang W; Li R; Pan HF; Ye DQ
Cell Immunol; 2012; 276(1-2):10-5. PubMed ID: 22560675
[TBL] [Abstract][Full Text] [Related]
19. cAMP-responsive element modulator (CREM)α protein induces interleukin 17A expression and mediates epigenetic alterations at the interleukin-17A gene locus in patients with systemic lupus erythematosus.
Rauen T; Hedrich CM; Juang YT; Tenbrock K; Tsokos GC
J Biol Chem; 2011 Dec; 286(50):43437-46. PubMed ID: 22025620
[TBL] [Abstract][Full Text] [Related]
20. A novel intronic cAMP response element modulator (CREM) promoter is regulated by activator protein-1 (AP-1) and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosus.
Rauen T; Benedyk K; Juang YT; Kerkhoff C; Kyttaris VC; Roth J; Tsokos GC; Tenbrock K
J Biol Chem; 2011 Sep; 286(37):32366-72. PubMed ID: 21757709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
